Comparison of treatment practices for nontuberculous mycobacterial pulmonary disease in Japan, Europe, and United States
J. van Ingen, J. Adjemian, K. Morimoto, D. Wagner, C. Lange, C. Haworth, J. Gallagher, D. R. Prevots, R. Gupta, D. Griffith (Nijmegen, Netherlands; Bethesda, Spartanburg, Monmouth Junction, Tyler, United States Of America; Tokyo, Japan; Freiburg, Borstel, Germany; Cambridge, United Kingdom)
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Session: The epidemiology of respiratory infections and lung cancer
Session type: Thematic Poster Session
Number: 1066
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. van Ingen, J. Adjemian, K. Morimoto, D. Wagner, C. Lange, C. Haworth, J. Gallagher, D. R. Prevots, R. Gupta, D. Griffith (Nijmegen, Netherlands; Bethesda, Spartanburg, Monmouth Junction, Tyler, United States Of America; Tokyo, Japan; Freiburg, Borstel, Germany; Cambridge, United Kingdom). Comparison of treatment practices for nontuberculous mycobacterial pulmonary disease in Japan, Europe, and United States. Eur Respir J 2014; 44: Suppl. 58, 1066
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Annual prevalence and treatment estimates of nontuberculous mycobacterial pulmonary disease in Europe: A NTM-NET collaborative study Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Epidemiology and clinical features of nontuberculous mycobacterial lung disease in a subtropical region in Japan: Analysis with a 7-year data in two major hospitals Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016
Non-tuberculous mycobacterium incidence & treatment rates in university hospitals of North Midlands (UK) Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
Tuberculosis (TB) screening in immigrants in a large city in the United Kingdom (UK) Source: Annual Congress 2006 - Epidemiology and control of tuberculosis Year: 2006
The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada Source: Eur Respir J 2011; 37: 1158-1165 Year: 2011
Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016
Molecular identification of nontuberculous mycobacteria isolated from patients in northeast Iran Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016
Differences in tuberculosis disease among immigrant and native populations Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013
The costs of MDR/XDR tuberculosis in Barcelona (Spain): Cases treated with DOTs/DOT plus in a specialized centre Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Nontuberculous mycobacteria in the Danish population, incidence rate and clinical importance during 24 years Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015
Effect of LAEDI (Local awareness and early diagnosis initiatives) in a low socioeconomic area population in United Kingdom Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014
TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Source: Eur Respir J 2012; 39: 619-625 Year: 2012
Asthma ICs prescriptions in primary care in France and the United Kingdom: Are they similar? Source: International Congress 2016 – Asthma management in primary care Year: 2016
Active detection of tuberculosis in homeless populations may reduce the incidence of tuberculosis in the general population Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Geographic origin and other determinants of site of tuberculosis disease in European countries Source: International Congress 2014 – Tuberculosis epidemiology: novel features Year: 2014
Screening immigrants to Ireland from countries with a high prevalence of tuberculosis would be clinically beneficial and cost effective Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013
Tuberculosis and HIV co-infection in European Union and European Economic Area countries Source: Eur Respir J 2011; 38: 1382-1392 Year: 2011
Nontuberculous mycobacterial disease of the lungs in North-West region of Russia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Comparison of tuberculosis surveillance systems in low-incidence industrialised countries Source: Eur Respir J 2008; 32: 1616-1624 Year: 2008
Prevalence of nontuberculous mycobacteria in hospital watersof major cities of Khuzestan province, Iran Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016